False
Advertisement
February 2017
Welcome to February’s issue. Upfront’s topics range from 3D-printed surgical tools to the 2017 Power List, and In My View sees Julian Stevens discuss why he believes it’s too soon for SMILE. In our Feature, we explore the bizarre world of factitious disorder with a psychiatrist and a neuroophthalmologist. In Practice sees two glaucoma specialists review laser-based techniques for reducing IOP, and Howard Petty discusses semiconducting nanoparticles for ocular cancer in Next Gen. In profession, three ophthalmologists share their experiences of setting up solo practices. Finally, we Sit Down With Mitch McCartney.
OCT for all, and all for OCT
March 2, 2017
Eye exams can detect more than ocular disease. Is there a place for it in general practice?
1 min read
In Conversation With…Theo Seiler, PhD
February 10, 2017
Prof. Theo Seiler explains why the AMARIS 1050RS is his excimer laser of choice
1 min read
Benchmarking Dry AMD
February 8, 2017
What does analysis of the last five years of dry AMD literature tell us about the priorities of the field and its major contributors?
1 min read
The Bot that Busts Clots
February 8, 2017
A world first: clinical use of a robot for retinal vein cannulation
1 min read
An Issue of Inequity
February 8, 2017
Poorer people suffer poorer outcomes across all of medicine. Can eyecare buck the trend?
1 min read
A User’s Guide to SLT
February 3, 2017
What benefits can SLT offer, and which patients are eligible?
1 min read
The Laser Quest for a Happy Medium
February 3, 2017
In glaucoma, medical management is plagued with noncompliance, and filtration surgery can be complex and risky. Could laser-based treatments offer a happy medium?
1 min read
A New Front in the War on Ocular Cancer
February 3, 2017
Could semiconducting nanoparticles improve the management of the debilitating disease?
1 min read
Hang that Shingle!
February 2, 2017
How we approached “going solo” and set up our own successful practices
1 min read
Truth, Lies, and Ophthalmology
February 2, 2017
Tips for the ophthalmologist confronted with functional vision loss
1 min read
Tales of the Unexpected
February 2, 2017
Factitious disorder in ophthalmology – a psychiatrist’s perspective
1 min read
Tech Support
February 2, 2017
For the blind and visually impaired, smartphones and specialist apps offer something that’s indispensable: independence
1 min read
Building a Better Biorepository
February 2, 2017
Sitting Down With... Mitch McCartney, Scientific Director, Lions Eye Institute for Transplant and Research, Florida, USA.
1 min read
Stranger Than Fiction
February 2, 2017
What motivates people to fake vision problems? And how should you deal with patients who are prone to fabricating the truth? Marc Feldman and Valerie Purvin share (some of) the answers...
1 min read
Know Your Worth
February 2, 2017
It’s time we remembered that our success is down to our skill – not our equipment.
1 min read
Too Soon to SMILE
February 2, 2017
Despite the emergence of alternatives, femtosecond LASIK remains at the cutting edge of vision correction.
1 min read
Tears of Blood
February 2, 2017
Are new oral anticoagulants more or less likely to cause intraocular bleeding than warfarin?
1 min read
Sex, Bucks, and Bills n’ Codes
February 2, 2017
How wide is the payment gap between male and female ophthalmologists?
1 min read
Long Live the Stem Cell!
February 2, 2017
hESCs transplanted into immunocompromised murine retina exhibit increased longevity and long-term functionality
1 min read
3D-Printable Prototypes
February 2, 2017
How to develop a new tool for strabismus surgery – using additive manufacturing
1 min read
Mouse Versus Monkey
February 1, 2017
New AAV vectors promise better retinal cell type targeting… in mice. But does this hold up in non-human primates?
1 min read
The Ophthalmologist Power List 2017
January 23, 2017
Who are the “rising stars” in ophthalmology?
1 min read
A Long Term Look at CLASS
January 18, 2017
The 5-year trial results are in. How safe and effective is the CLASS procedure?
1 min read
This Month in Business
September 5, 2016
TrueVision and Alcon team-up on “heads-up” technology, Pfizer returns rights to ranibizumab biosimilar, and more...
1 min read
Browse by Subspecialties
False
Advertisement